Clinical trial
An Open-Label Study of Cysteamine Bitartrate in Treatment-Resistant Major Depression
NCT00715559 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label Study of Cysteamine Bitartrate in Treatment-Resistant Major Depression
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- July 31, 2008
- Completion date
- May 31, 2009
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.